A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
The purpose of this study is to evaluate the efficacy and safety of GC1102 in combination of Nucleo(t)ide analogues (NAs) in patients with chronic hepatitis B
Epistemonikos ID: e14fc961062d002bc2b6ba40249c8e589704c271
First added on: Nov 24, 2021